All Stories

  1. Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation
  2. Delivering LINE1 antisense oligonucleotides via endothelial targeting extracellular vesicles to ameliorate myocardial infarction-induced cardiac senescence
  3. Topical application of a placental mesenchymal stem cell-embedded biomaterial hydrogel accelerates the repair of radiation-induced skin damage: a double-blind randomized phase II clinical trial
  4. The Impact of Delayed Fusion of Amnion and Chorion on Maternal and Fetal Outcomes: A Prospective Cohort Study
  5. ZFP560 facilitates KAP1-dependent chromatin repression to regulate exit from totipotency
  6. Network pharmacology and experimental verification: Rosmarinic acid alleviates doxorubicin-induced cardiomyocyte apoptosis by regulating BCL2L1
  7. Nitric oxide-primed engineered extracellular vesicles restore bioenergetics in acute kidney injury via mitochondrial transfer
  8. Extracellular vesicles derived from mesenchymal stem cells alleviate renal fibrosis via the miR-99b-5p/mTOR/autophagy axis in diabetic kidney disease
  9. Engineered extracellular vesicles promote the repair of acute kidney injury by modulating regulatory T cells and the immune microenvironment
  10. IL-1β stimulates ADAMTS9 expression and contributes to preterm prelabor rupture of membranes
  11. The Future of Healthcare: Pharmaceutical Nanotechnology
  12. Lineage Tracing Reveals that the Activation of Endogenous Sox9+ Cells Promotes Kidney Regeneration After Acute Kidney Injury
  13. Healing action of Interleukin-4 (IL-4) in acute and chronic inflammatory conditions: Mechanisms and therapeutic strategies
  14. Correction to “In Vivo Real-Time Imaging of Extracellular Vesicles in Liver Regeneration via Aggregation-Induced Emission Luminogens”
  15. Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease
  16. Hyaluronic acid-modified extracellular vesicles for targeted doxorubicin delivery in hepatocellular carcinoma
  17. Ligand‐Tethered Extracellular Vesicles Mediated RNA Therapy for Liver Fibrosis
  18. WITHDRAWN: Mesenchymal Stem Cells in Clinical Trials for Immune Disorders
  19. Phosphatidylserine-mediated uptake of extracellular vesicles by hepatocytes ameliorates liver ischemia-reperfusion injury
  20. Extracellular vesicles derived from mesenchymal stem cells suppress breast cancer progression by inhibiting angiogenesis
  21. Biomimetic Supramolecular Assembly with IGF‐1C Delivery Ameliorates Inflammatory Bowel Disease (IBD) by Restoring Intestinal Barrier Integrity
  22. Therapeutic trends of priming mesenchymal stem cells: A bibliometric analysis
  23. iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review
  24. Combined lineage tracing and scRNA‐seq reveal the activation of Sox9+ cells in renal regeneration with PGE2 treatment
  25. Extracellular vesicles: A new frontier in the theranostics of cardiovascular diseases
  26. In vivo tracking of mesenchymal stem cell dynamics and therapeutics in LPS-induced acute lung injury models
  27. Biomaterials and Mesenchymal Stem Cells
  28. Pioneering the Future of Medicine: Exploring the Frontiers of Pharmaceutical Nanotechnology
  29. PAFAH2 suppresses synchronized ferroptosis to ameliorate acute kidney injury
  30. Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases
  31. Mesenchymal Stem Cells in Clinical Trials for Immune Disorders
  32. Extracellular Vesicle: Biology and Translational Application
  33. Extracellular Vesicles in Pregnancy: Functional Insights, Diagnostic Potential for Maternal–Fetal Disorders, and Therapeutic Implications
  34. Extracellular Vesicles: Tiny Packages with Big Potential
  35. Mesenchymal stem cell-derived extracellular vesicles targeting irradiated intestine exert therapeutic effects
  36. Regulation and Mechanisms of Exosome Cargo Selection and Secretion
  37. Technologies for EV Surface Modification and its Application in Targeted Therapy
  38. The Significance of Biomaterials in Stem Cell-Based Regenerative Medicine
  39. Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
  40. Embryonic stem cell-derived extracellular vesicles rejuvenate senescent cells and antagonize aging in mice
  41. Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy
  42. Subconjunctival Administration of Mesenchymal Stem Cells Alleviates Ocular Inflammation in a Murine Model of Corneal Alkali Burn
  43. Superior protective effects of PGE2 priming mesenchymal stem cells against LPS-induced acute lung injury (ALI) through macrophage immunomodulation
  44. Mesenchymal stem cells: A promising weapon for cancer therapy
  45. The enhanced therapeutic potential of MSC with biomaterials application
  46. Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy
  47. Off-the-shelf GMP-grade UC-MSCs as therapeutic drugs for the amelioration of CCl4-induced acute-on-chronic liver failure in NOD-SCID mice
  48. Enhancement of hair growth through stimulation of hair follicle stem cells by prostaglandin E2 collagen matrix
  49. The RGD-modified self-assembling D-form peptide hydrogel enhances the therapeutic effects of mesenchymal stem cells (MSC) for hindlimb ischemia by promoting angiogenesis
  50. Heparan sulfate proteoglycan-mediated internalization of extracellular vesicles ameliorates liver fibrosis by targeting hepatic stellate cells
  51. Renal Endothelial Cell‐Targeted Extracellular Vesicles Protect the Kidney from Ischemic Injury
  52. Advances and Perspectives of Pharmaceutical Nanotechnology in mRNA therapy
  53. Biosynthetic Dendritic Cell-Exocytosed Aggregation-Induced Emission Nanoparticles for Synergistic Photodynamic Immunotherapy
  54. Changes in serum angiogenic factors among patients with acute pain and subacute pain
  55. Therapeutic application of tumour cell‐derived extracellular vesicles for drug‐resistant cancer therapy via interleukin 6/signal transducer and activator of transcription 3 signalling pathway
  56. Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection
  57. Maternal Factor Dppa3 Activates 2C-Like Genes and Depresses DNA Methylation in Mouse Embryonic Stem Cells
  58. Nitric oxide improves regeneration and prevents calcification in bio-hybrid vascular grafts via regulation of vascular stem/progenitor cells
  59. A supramolecular hydrogel based on the combination of YIGSR and RGD enhances mesenchymal stem cells paracrine function via integrin α2β1 and PI3K/AKT signaling pathway for acute kidney injury therapy
  60. Dppa3 facilitates self-renewal of embryonic stem cells by stabilization of pluripotent factors
  61. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia
  62. Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice
  63. The sustained PGE2 release matrix improves neovascularization and skeletal muscle regeneration in a hindlimb ischemia model
  64. Editorial
  65. Transient upregulation of EGR1 signaling enhances kidney repair by activating SOX9+ renal tubular cells
  66. Constructing a cell microenvironment with biomaterial scaffolds for stem cell therapy
  67. High TSPAN8 expression in epithelial cancer cell‐derived small extracellular vesicles promote confined diffusion and pronounced uptake
  68. Renal subcapsular delivery of PGE2 promotes kidney repair by activating endogenous Sox9+ stem cells
  69. Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Radiation-Induced Lung Injury via miRNA-214-3p
  70. Extracellular vesicles derived from mesenchymal stem cells as a potential therapeutic agent in acute kidney injury (AKI) in felines: review and perspectives
  71. Platelet extracellular vesicles enhance the proangiogenic potential of adipose-derived stem cells in vivo and in vitro
  72. Embryonic stem cell-derived extracellular vesicles promote the recovery of kidney injury
  73. Meet the Editor-in-Chief
  74. Intravital microscopy imaging of kidney injury and regeneration
  75. CD73+ Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis
  76. Chitosan hydrogel-loaded MSC-derived extracellular vesicles promote skin rejuvenation by ameliorating the senescence of dermal fibroblasts
  77. Sulfated glycosaminoglycans in decellularized placenta matrix as critical regulators for cutaneous wound healing
  78. Isolation and Multiple Differentiation of Rat Pericardial Fluid Cells
  79. Intranasal delivery of MSC-derived exosomes attenuates allergic asthma via expanding IL-10 producing lung interstitial macrophages in mice
  80. Multifaceted Optimization of MSC-Based Formulation upon Sodium Iodoacetate-Induced Osteoarthritis Models by Combining Advantageous HA/PG Hydrogel and Fluorescent Tracer
  81. The delivery of hsa-miR-11401 by extracellular vesicles can relieve doxorubicin-induced mesenchymal stem cell apoptosis
  82. Two-step generation of mesenchymal stem/stromal cells from human pluripotent stem cells with reinforced efficacy upon osteoarthritis rabbits by HA hydrogel
  83. Role of prostaglandin E2 in tissue repair and regeneration
  84. Applications of Decellularized Extracellular Matrix for Regenerative Medicine
  85. Arf6-mediated macropinocytosis-enhanced suicide gene therapy of C16TAB-condensed Tat/pDNA nanoparticles in ovarian cancer
  86. Chitosan Hydrogel-loaded MSC-derived Extracellular Vesicles Promote Skin Rejuvenation by Ameliorating the Senescence of Dermal Fibroblasts
  87. <p>Celecoxib Exerts a Therapeutic Effect Against Demyelination by Improving the Immune and Inflammatory Microenvironments</p>
  88. Spatio-Temporal Metabolokinetics and Efficacy of Human Placenta-Derived Mesenchymal Stem/Stromal Cells on Mice with Refractory Crohn’s-like Enterocutaneous Fistula
  89. A nitric oxide-releasing hydrogel for enhancing the therapeutic effects of mesenchymal stem cell therapy for hindlimb ischemia
  90. Supramolecular Nanofibers Containing Arginine-Glycine-Aspartate (RGD) Peptides Boost Therapeutic Efficacy of Extracellular Vesicles in Kidney Repair
  91. In vivo two-photon microscopy reveals the contribution of Sox9+ cell to kidney regeneration in a mouse model with extracellular vesicle treatment
  92. Abstract 328: Enhanced Therapeutic Effects of Mesenchymal Stem Cells for Hindlimb Ischemia by a Nitric Oxide Hydrogel Through Mesenchymal-endothelial Transition
  93. Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in�mice by inhibiting inflammation and oxidative stress
  94. IGF-1C domain-modified chitosan hydrogel accelerates cutaneous wound healing by promoting angiogenesis
  95. <p>Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy</p>
  96. Correction to: IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
  97. Enhanced therapeutic effects of MSC-derived extracellular vesicles with an injectable collagen matrix for experimental acute kidney injury treatment
  98. In Vivo Tracking of Mesenchymal Stem Cell-Derived Extracellular Vesicles Improving Mitochondrial Function in Renal Ischemia–Reperfusion Injury
  99. IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
  100. Human Supernumerary Teeth-Derived Apical Papillary Stem Cells Possess Preferable Characteristics and Efficacy on Hepatic Fibrosis in Mice
  101. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization
  102. Mesenchymal Stem Cell-Derived Extracellular Vesicles for Corneal Wound Repair
  103. The Application of Methylprednisolone Nanoscale Zirconium-Porphyrin Metal-Organic Framework (MPS-NPMOF) in the Treatment of Photoreceptor Degeneration
  104. Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease
  105. Nitric‐Oxide‐Releasing Biomaterial Regulation of the Stem Cell Microenvironment in Regenerative Medicine
  106. Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
  107. The role of biomaterials in stem cell-based regenerative medicine
  108. JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia
  109. MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia
  110. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia
  111. In Vivo Real-Time Imaging of Extracellular Vesicles in Liver Regeneration via Aggregation-Induced Emission Luminogens
  112. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model
  113. Molecular Imaging of Therapeutic Effect of Mesenchymal Stem Cell-Derived Exosomes for Hindlimb Ischemia Treatment
  114. Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells
  115. Introduction of Perinatal Tissue-Derived Stem Cells
  116. Perinatal Stem Cells in Kidney Regeneration: Current Knowledge and Perspectives
  117. Proangiogenic Features of Perinatal Tissue-Derived Stem Cells in Cardiovascular Disease Therapy
  118. Perinatal Stem Cells
  119. Folic acid-nanoscale gadolinium-porphyrin metal-organic frameworks: fluorescence and magnetic resonance dual-modality imaging and photodynamic therapy in hepatocellular carcinoma
  120. Dppa3 is critical for Lin28a-regulated ES cells naïve–primed state conversion
  121. Dppa3 in pluripotency maintenance of ES cells and early embryogenesis
  122. MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway
  123. Stat3 activation is critical for pluripotency maintenance
  124. Enhanced Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment
  125. Abstract 490: Enhanced Therapeutic Effects of MSC-derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment
  126. Directed Differentiation of Human Corneal Endothelial Cells From Human Embryonic Stem Cells by Using Cell-Conditioned Culture Media
  127. Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction
  128. Current View on Hematopoiesis and Beyond
  129. Comparison of Teratoma Formation between Embryonic Stem Cells and Parthenogenetic Embryonic Stem Cells by Molecular Imaging
  130. VE-Cadherin regulates the self-renewal of mouse embryonic stem cells via LIF/Stat3 signaling pathway
  131. Knockout of zebrafish interleukin 7 receptor (IL7R) by the CRISPR/Cas9 system delays retinal neurodevelopment
  132. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway
  133. Inflammatory Human Umbilical Cord-Derived Mesenchymal Stem Cells Promote Stem Cell-Like Characteristics of Cancer Cells in an IL-1β-Dependent Manner
  134. Hydrogel-Based Strategies for Stem Cell Therapy
  135. Prostaglandin E2 hydrogel improves cutaneous wound healing via M2 macrophages polarization
  136. Nitric oxide releasing hydrogel promotes endothelial differentiation of mouse embryonic stem cells
  137. A macroporous heparin-releasing silk fibroin scaffold improves islet transplantation outcome by promoting islet revascularisation and survival
  138. Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence
  139. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer
  140. Down-regulation of interleukin 7 receptor (IL-7R) contributes to central nervous system demyelination
  141. Stat3 phosphorylation is required for embryonic stem cells ground state maintenance in 2i culture media
  142. Three structurally related Copper complexes with two isomers: DNA/BSA binding ability, DNA cleavage activity and excellent cytotoxicity
  143. Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats
  144. Molecular Imaging of Inducible VEGF Expression and Tumor Progression in a Breast Cancer Model
  145. LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling
  146. Meet Our Editorial Board Member
  147. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta
  148. Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction
  149. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer
  150. Interferon-γ alters the microRNA profile of umbilical cord-derived mesenchymal stem cells
  151. Erratum: Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects
  152. Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer
  153. Bone Marrow Is a Reservoir for Cardiac Resident Stem Cells
  154. Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects
  155. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis
  156. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity
  157. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects
  158. IGF-1 C Domain–Modified Hydrogel Enhances Cell Therapy for AKI
  159. Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
  160. Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications
  161. Controlled nitric oxide release for tissue repair and regeneration
  162. Translational applications of molecular imaging in cardiovascular disease and stem cell therapy
  163. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
  164. Extracellular Matrix can Recover the Downregulation of Adhesion Molecules after Cell Detachment and Enhance Endothelial Cell Engraftment
  165. Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells
  166. Activating Transcription Factor 4 Promotes Angiogenesis of Breast Cancer through Enhanced Macrophage Recruitment
  167. Angiogenesis
  168. Molecular Imaging: The Key to Advancing Stem Cell Therapy
  169. OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction
  170. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells
  171. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle
  172. Phase dependent luminescent property of N,N-di(n-octyl)quinacridone crystals
  173. Traceable Therapeutic Strategy for Treatment of Breast Cancer with Mesenchymal Stem Cells (MSCs)
  174. IFN-γ mediates graft-versus-breast cancer effects via enhancing cytotoxic T lymphocyte activity
  175. Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy
  176. Synthesis, Biodistribution, and Imaging of PEGylated-Acetylated Polyamidoamine Dendrimers
  177. Tumor necrosis factor-α regulates matrix metalloproteinase-2 expression and cell migration via ERK pathway in rat glomerular mesangial cells
  178. Bone Marrow Vascular Niche: Home for Hematopoietic Stem Cells
  179. Nanoparticle-Based Tumor Theranostics with Molecular Imaging
  180. The role of Hath6, a newly identified shear-stress-responsive transcription factor, in endothelial cell differentiation and function
  181. Human Embryonic Stem Cell-Derived Endothelial Cells as Cellular Delivery Vehicles for Treatment of Metastatic Breast Cancer
  182. Noninvasive Imaging of Hypoxia-Inducible Factor-1α Gene Therapy for Myocardial Ischemia
  183. Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53
  184. Human embryonic stem cells-derived endothelial cell therapy facilitates kidney regeneration by stimulating renal resident stem cell proliferation in acute kidney injury
  185. Imaging Neural Stem Cell Graft-Induced Structural Repair in Stroke
  186. The Phenotypic Fate of Bone Marrow-Derived Stem Cells in Acute Kidney Injury
  187. Bioluminescence Imaging of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction
  188. Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction
  189. Assessment of Therapeutic Efficacy of Liposomal Nanoparticles Mediated Gene Delivery by Molecular Imaging for Cancer Therapy
  190. Bone marrow-derived cells can acquire renal stem cells properties and ameliorate ischemia-reperfusion induced acute renal injury
  191. Improved mesenchymal stem cell survival in ischemic heart through electroacupuncture
  192. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma
  193. Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer
  194. Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy
  195. Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma
  196. Abstract 415: Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for targeting therapy of metastatic breast cancer
  197. Exosomes for Ophthalmic Therapeutics
  198. Functional Characterization and Expression Profiling of Human Induced Pluripotent Stem Cell- and Embryonic Stem Cell-Derived Endothelial Cells
  199. Novel MicroRNA Prosurvival Cocktail for Improving Engraftment and Function of Cardiac Progenitor Cell Transplantation
  200. Preparation and Evaluation of Magnetic Nanoparticles for Cell Labeling
  201. Abstract 2464: Targeting liver cancer stem cells for molecular imaging and therapeutic application
  202. Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation
  203. Effects of Long-Term Culture on Human Embryonic Stem Cell Aging
  204. MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
  205. Effects of Ionizing Radiation on Self-Renewal and Pluripotency of Human Embryonic Stem Cells
  206. Embryonic Stem Cell–Derived Endothelial Cells Engraft Into the Ischemic Hindlimb and Restore Perfusion
  207. Human Neural Stem Cell Grafts Modify Microglial Response and Enhance Axonal Sprouting in Neonatal Hypoxic–Ischemic Brain Injury
  208. A nonviral minicircle vector for deriving human iPS cells
  209. Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction
  210. nAChRs Mediate Human Embryonic Stem Cell-Derived Endothelial Cells: Proliferation, Apoptosis, and Angiogenesis
  211. Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction
  212. Molecular and Magnetic Resonance Imaging of Human Embryonic Stem Cell–Derived Neural Stem Cell Grafts in Ischemic Rat Brain
  213. Imaging Survival and Function of Transplanted Cardiac Resident Stem Cells
  214. Imaging of STAT3 Signaling Pathway During Mouse Embryonic Stem Cell Differentiation
  215. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases
  216. Short Hairpin RNA Interference Therapy for Ischemic Heart Disease
  217. Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality
  218. Comparison of Reporter Gene and Iron Particle Labeling for Tracking Fate of Human Embryonic Stem Cells and Differentiated Endothelial Cells in Living Subjects
  219. Genetic Modification of Embryonic Stem Cells with VEGF Enhances Cell Survival and Improves Cardiac Function
  220. Differentiation, Survival, and Function of Embryonic Stem Cell Derived Endothelial Cells for Ischemic Heart Disease
  221. Positron emission tomography imaging of conditional gene activation in the heart
  222. Molecular Imaging of Embryonic Stem Cell Misbehavior and Suicide Gene Ablation
  223. Quantum dot imaging for embryonic stem cells
  224. Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro
  225. Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation
  226. Enhancement of neovascularization with cord blood CD133 + cells-derived endothelial progenitor cells transplantation